Budget Proposals Have Myriad Effects on the Industry

Slides:



Advertisements
Similar presentations
Medicare and Prescription Drugs: Issues for Employers and Consumers Robert D. Reischauer The Urban Institute National Health Policy Conference January.
Advertisements

THE COMMONWEALTH FUND Source: Commonwealth Fund/Modern Healthcare Health Care Opinion Leaders Survey, February Exhibit 1. Views on the Affordable.
The Nebraska BLUES Reform Impact Study Pat Bourne.
Government Influences on Cigna Business Acumen Course August 27 th, 2014.
PPACA IMPACT ON MEMBER INSTITUTIONS Why would you be Confused?
PE and Health Care Reform: The Impact of the Supreme Court Ruling July 12, 2012 To enable audio, please enter the audio pin followed by the.
THE AIDS INSTITUTE The AIDS Institute HEALTH REFORM AND ADAP Emily McCloskey, Public Policy Associate Carl Schmid, Deputy Executive Director AIDS Drug.
MEDICARE: PAST, PRESENT AND FUTURE James G. Anderson, Ph.D. Department of Sociology & Anthropology.
The Young and Uninsured in NY: Impact on Physician Offices Robert L. Cafone, MPA, RPA-C Chief Executive Officer Mid Coastal Independent Physician Association.
Hospital Reimbursement: - The Reimbursement Hydraulic - Cost Shifting.
Medicare Part D: How Can You Assist Seniors in Your Life? Tim Jongerius, FSA, MAAA Sr. Actuary Wellmark Blue Cross Blue Shield of Iowa Iowa Actuaries Club.
The New Health Care Reform: Explaining Changes To Medicare Beneficiaries.
Health Reform: What It Means to Our Community. Health Reform: Key Provisions o Provides coverage to 32 million uninsured people by o Changes insurance.
Clinical Laboratory Testing: Providing Clinical Evidence for Diagnosis and Treatment Alan Mertz President American Clinical Laboratory Association.
Health Care Reform Provision
1 State Perspectives on Medicare Part D: Lessons from Pharmacy Plus Programs Cindy Parks Thomas Donald Shepard Christine E. Bishop Daniel M. Gilden Brandeis.
Understanding Health Reform CHOICE Regional Health Network.
Universal Coverage… “Pharmaceutical Benefit Management” or “Pharmacy Benefit Management” is the set of rules, controls and enforcement tools that define.
Early Treatment of HIV Summit Washington DC July 20, 2009 Carl Schmid Deputy Executive Director The AIDS Institute William McColl Political Director AIDS.
 The Impact of the Medicare Prescription Drug Legislation on Pharmaceutical Revenues Presented By: Jack Rodgers PricewaterhouseCoopers February 27,
The Patient Protection and Affordable Care Act Our Healthcare Reform Law Why do we need it? What does it do for us?
Find Your Way Around The Health Care Law. 2 Agenda People with health insurance People who are uninsured or buy their own coverage People with Medicare.
The New Medicare Prescription Drug Benefit: An Overview Prepared by: Michelle Kitchman, M.H.S. Kaiser Family Foundation For the: California Senate Health.
Health Care Reform Update September 2010 Michael Mayers Ken Preede Policy & Government Advocacy Department.
Stretching Program Dollars: Creative Solutions in Cost Containment Presentation to aaa+ ADAP Crisis Summit July 6, 2010.
Chapter 6 Home Health. Copyright © 2005 by Thomson Delmar Learning. ALL RIGHTS RESERVED.2 Number of Medicare-Certified Home Health Agencies,
Ian D. Spatz Merck & Co., Inc. January 14, 2004 Ian D. Spatz Merck & Co., Inc. January 14, 2004 Overview of the New Medicare Prescription Drug Law.
2011 MEDICAL SEMINAR. WHAT DO WE BELIEVE? Media “Experts” Government HealthCare.gov.
Healthcare Issues for Businesses Indiana Advanced Aerospace Manufacturing Alliance December 5, 2008.
K A I S E R C O M M I S S I O N O N Medicaid and the Uninsured Figure 0 Medicare Modernization Act of 2003: Implications for Low-Income People and State.
National Health Care Reform: Yet another remedy for Oklahoma’s uninsured? Mike Fogarty, MSW, JD CEO, Oklahoma Health Care Authority April 9,
Leading Through Health Reform Karen Minyard, Ph.D.
Avalere Health LLC | The intersection of business strategy and public policy The Medicare Modernization Act: The Impact on States and Low-Income Beneficiaries.
on the Medicare Part D Donut Hole
1 Medicare Reform: Implications for Pharmaceutical Manufacturers G. Lawrence Atkins, PhD Schering-Plough Corporation January 14, 2004.
Alliance for Health Reform Briefing: What’s in There? An Ask-the-Experts Overview of the Health Reform Law April 16, 2010 Dean A. Rosen, Partner
CMS Overview of Program Administration Medicare Coverage Gap Discount Program Public Meeting June 1, 2010.
© South-Western Educational Publishing Chapter 27 Health and Life Insurance  Health Insurance  Disability and Life Insurance.
Estimating the Cost of the Medicare Drug Benefit Philip Ellis Steve Lieberman Medicare Prescription Drug Congress February 27, 2004.
Balancing Value and Access to Innovative Medicines The HSE Experience.
MEDICATION USE IN RURAL AMERICA ASSOCIATION UPDATES National Community Pharmacists Association Tina Schlecht, PharmD, MBA Director, Pharmacy Affairs.
Newark CSD Board of Education February 10, Budget Discussion.
Health Reform: What It Means to Our Community
Health Care Literacy: More Important Than Ever
North Carolina Medicare Part D
MMA, Private Plans, and Competition: Commercial Health Plan Response to MMA November 1, 2005 David F. Ogden, F.S.A. Milliman, Inc.
Policy Provisions Under Three Reform Scenarios
Providing A Safety Net 3.4.
The large majority of leaders support reform options in President Obama’s budget blueprint. “The following is a list of specific policies that have recently.
Express Scripts Exclusions Target 25 Drug Classes
Healthcare Reform and Medicare Part D
Health Strategies Group
GOVERNMENT AND THE MARKET FOR HEALTH CARE
Answers to insurance wkst
National Medicare Prescription Drug Congress
The Future of Biologics in Part D
Medicare Rx Legislation: Implications for PBMs
New Coverage for 45 Million Uninsured 12m 19m 13m <1m
Direct Medicare Price Negotiation is Good for Payers
What Lies Ahead for the Employment-Based Health Benefits System?
Medicare Rx Drug Benefit
Medical Loss Ratios and Rebates by Insurance Market Segment, 2011–2013
CENTER FOR MEDICARE ADVOCACY, INC.
Troy Wieck, ASA, MAAA Sr. Director, Actuarial Services March 20, 2018
Medicare Reform: Implications for Pharmaceutical Manufacturers
Pharmacy Benefit Manager
Policy Provisions Under Three Reform Scenarios
Modest Increase In Support For Single-Payer Health Care Over Time
Where do the Democratic Candidates Stand on Health Reform?
Where do the Democratic Candidates Stand on Health Reform
Presentation transcript:

Budget Proposals Have Myriad Effects on the Industry Source: Retrieved from: https://www.appropriations.senate.gov/imo/media/doc/Bipartisan%20Budget%20Act%20of%202018.pdf, accessed February 2018; Health Strategies Group, Value, Quality, and Reimbursement, and Insurance Benefit Design, February 2018. Medicare POS rebates pass-through Test eliminating Medicaid best price Medicare biosimilar discount Part B payment changes Medicare catastrophic limits Expanded MA benefits Level of Impact Effect on Business Low Medium High + – Neg Pos Star ratings adjustment IPAB repeal Medicaid line extension penalty Part D formulary narrowing New Medicare drug price reporting rules Faster Medicare coverage gap fill Medicare Part B to D shifts